European Research Associates, Ltd. et al.; Withdrawal of Approval of Three New Drug Applications

摘要

The Food and Drug Administration (FDA) is withdrawing approval of three new drug applications (NDA's). The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports on these NDA's.